Know All About Mikhail Blagosklonny

Mikhail Blagosklonny has been appointed at the Roswell Park Cancer Institute, New York as its Professor of Oncology. In addition, Dr. Mikhail Blagosklonny has authored more than 170 research articles, in addition to reviews as well as book chapters. He is the Editor-in-Chief of Cancer Biology & Therapy, besides Cancer Research, as well as Autophagy, along with American Journal of Pathology.

Mikhail Blagosklonny has a wide range of research interests. These include molecular and cellular biology, clinical investigations, signal transduction, besides cell cycle and cellular senescence. He is also conducting research on anticancer therapeutics where he is looking at translating basic science into anti-cancer strategies. His research on signal transduction pathways has moved from cancer to aging. Hence he is looking at revealing potential targets that can help to slow down aging along with any age-related diseases.

He has been able to develop highly unique concepts which are related to cancer biology as well as its therapy. He will be able to facilitate developing of various anticancer strategies along with cancer therapy methods as well as its prevention. View Mikhail’s profile on Google Scholar

There are a number of ideas as well as approaches that are being tested out here. These include protecting normal cells during chemotherapy, looking at specific combinations possible of anti-cancer drugs, anti-tissue therapy for treating cancer, besides looking at ways for preventing cancer.

A paper of Mikhail Blagosklonny focuses on prevention of terming aging as any disease that needs to be cured. He propagates this idea as highly unscientific and completely misguided.

Aging was being considered as a functional decline that happens due to molecular damage getting accumulated. It was something that was considered to be impossible to prevent. But now the hyper-function theory is trying to break this belief. It is considering aging as a simple continuation of growth.

Mikhail Blagosklonny is predicting that rapamycin along with other rapalogs will be helpful in humans for treating aging as well as in preventing diseases. These will have to be given in proper doses in order to ensure that rapamycin along with other rapalogs can extend healthy life-span in the case of humans. Read more about Mikhail at LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *